Hospitalizations in adult patients with congenital heart disease: an emerging challenge

Despoina Ntiloudi1, Konstantinos Dimopoulos2, Aphrodite Tzifa3,4

  • 1Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kyriakidi str 1, 546 36, Thessaloniki, Greece.

Heart Failure Reviews
|September 11, 2020
PubMed

Insights

Adults with congenital heart disease (ACHD) face frequent hospitalizations due to complications like heart failure (HF). Identifying hospitalization predictors is crucial for timely interventions and improved outcomes in this growing population.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease (ACHD)

Background:

  • Most patients with congenital heart disease (CHD) now survive into adulthood, leading to a growing population of adults with CHD (ACHD).
  • ACHD patients experience lifelong complications, frequently necessitating hospital admissions.
  • Heart failure (HF) is a primary driver of morbidity and mortality in ACHD, increasing healthcare system burden.

Purpose of the Study:

  • To review current literature on hospitalization patterns in ACHD patients.
  • To focus on heart failure (HF)-related admissions and specific diagnostic subgroups within the ACHD population.
  • To understand predictors of hospitalization and in-hospital mortality in ACHD.

Main Methods:

  • Literature review of hospitalization patterns in ACHD.
  • Analysis of factors contributing to increased admissions, including HF, mild lesions, comorbidities, and pregnancies.
  • Examination of in-hospital mortality rates and their predictors.

Main Results:

  • Hospitalizations in ACHD are increasing, driven by HF, mild lesions, comorbidities, and pregnancies.
  • In-hospital mortality ranges from 0.8% to 6.1%.
  • HF-related hospitalizations are significant predictors of medium-term mortality in ACHD.

Conclusions:

  • Understanding ACHD hospitalization patterns is vital for healthcare providers.
  • Identifying patients at high risk for hospitalization and mortality is essential for treatment escalation and monitoring.
  • Further research into specific diagnostic subgroups and HF management in ACHD is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
236
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
181
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
265
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
280
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
149